A citation-based method for searching scientific literature

Kajal Biswas, Gary B Lipton, Stacey Stauffer, Teresa Sullivan, Linda Cleveland, Eileen Southon, Susan Reid, Valentin Magidson, Edwin S Iversen, Shyam K Sharan. NPJ Genom Med 2020
Times Cited: 4







List of co-cited articles
37 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Functional assays for analysis of variants of uncertain significance in BRCA2.
Lucia Guidugli, Aura Carreira, Sandrine M Caputo, Asa Ehlen, Alvaro Galli, Alvaro N A Monteiro, Susan L Neuhausen, Thomas V O Hansen, Fergus J Couch, Maaike P G Vreeswijk. Hum Mutat 2014
70
75

A comprehensive functional characterization of BRCA2 variants associated with Fanconi anemia using mouse ES cell-based assay.
Kajal Biswas, Ranabir Das, Blanche P Alter, Sergey G Kuznetsov, Stacey Stauffer, Susan L North, Sandra Burkett, Lawrence C Brody, Stefan Meyer, R Andrew Byrd,[...]. Blood 2011
35
75

Truncated BRCA2 is cytoplasmic: implications for cancer-linked mutations.
B H Spain, C J Larson, L S Shihabuddin, F H Gage, I M Verma. Proc Natl Acad Sci U S A 1999
109
50

Distinct binding of BRCA2 BRC repeats to RAD51 generates differential DNA damage sensitivity.
Gouri Chatterjee, Judit Jimenez-Sainz, Thomas Presti, Tiffany Nguyen, Ryan B Jensen. Nucleic Acids Res 2016
31
50

Interactions between human BRCA2 protein and the meiosis-specific recombinase DMC1.
Tina Thorslund, Fumiko Esashi, Stephen C West. EMBO J 2007
77
50

Double-strand break repair-independent role for BRCA2 in blocking stalled replication fork degradation by MRE11.
Katharina Schlacher, Nicole Christ, Nicolas Siaud, Akinori Egashira, Hong Wu, Maria Jasin. Cell 2011
719
50

Mouse embryonic stem cell-based functional assay to evaluate mutations in BRCA2.
Sergey G Kuznetsov, Pentao Liu, Shyam K Sharan. Nat Med 2008
92
50

Nuclear localization signals of the BRCA2 protein.
K Yano, K Morotomi, H Saito, M Kato, F Matsuo, Y Miki. Biochem Biophys Res Commun 2000
43
50

The functional impact of variants of uncertain significance in BRCA2.
Romy L S Mesman, Fabienne M G R Calléja, Giel Hendriks, Bruno Morolli, Branislav Misovic, Peter Devilee, Christi J van Asperen, Harry Vrieling, Maaike P G Vreeswijk. Genet Med 2019
29
50


BRCA2 is required for homology-directed repair of chromosomal breaks.
M E Moynahan, A J Pierce, M Jasin. Mol Cell 2001
698
50

Systematic misclassification of missense variants in BRCA1 and BRCA2 "coldspots".
Jennifer N Dines, Brian H Shirts, Thomas P Slavin, Tom Walsh, Mary-Claire King, Douglas M Fowler, Colin C Pritchard. Genet Med 2020
9
50

Purified human BRCA2 stimulates RAD51-mediated recombination.
Ryan B Jensen, Aura Carreira, Stephen C Kowalczykowski. Nature 2010
417
50

High-throughput functional evaluation of BRCA2 variants of unknown significance.
Masachika Ikegami, Shinji Kohsaka, Toshihide Ueno, Yukihide Momozawa, Satoshi Inoue, Kenji Tamura, Akihiko Shimomura, Noriko Hosoya, Hiroshi Kobayashi, Sakae Tanaka,[...]. Nat Commun 2020
13
50

A cancer-associated BRCA2 mutation reveals masked nuclear export signals controlling localization.
Anand D Jeyasekharan, Yang Liu, Hiroyoshi Hattori, Venkat Pisupati, Asta Bjork Jonsdottir, Eeson Rajendra, Miyoung Lee, Elayanambi Sundaramoorthy, Simon Schlachter, Clemens F Kaminski,[...]. Nat Struct Mol Biol 2013
61
50

Functional evaluation and cancer risk assessment of BRCA2 unclassified variants.
Kangjian Wu, Shannon R Hinson, Akihiro Ohashi, Daniel Farrugia, Patricia Wendt, Sean V Tavtigian, Amie Deffenbaugh, David Goldgar, Fergus J Couch. Cancer Res 2005
102
50

Assessment of the Clinical Relevance of BRCA2 Missense Variants by Functional and Computational Approaches.
Lucia Guidugli, Hermela Shimelis, David L Masica, Vernon S Pankratz, Gary B Lipton, Namit Singh, Chunling Hu, Alvaro N A Monteiro, Noralane M Lindor, David E Goldgar,[...]. Am J Hum Genet 2018
35
50

Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2.
S K Sharan, M Morimatsu, U Albrecht, D S Lim, E Regel, C Dinh, A Sands, G Eichele, P Hasty, A Bradley. Nature 1997
849
50

Distinct roles of BRCA2 in replication fork protection in response to hydroxyurea and DNA interstrand cross-links.
Kimberly A Rickman, Raymond J Noonan, Francis P Lach, Sunandini Sridhar, Anderson T Wang, Avinash Abhyankar, Athena Huang, Michael Kelly, Arleen D Auerbach, Agata Smogorzewska. Genes Dev 2020
20
50

Functional evaluation of BRCA2 variants mapping to the PALB2-binding and C-terminal DNA-binding domains using a mouse ES cell-based assay.
Kajal Biswas, Ranabir Das, Julie M Eggington, Huanyu Qiao, Susan L North, Stacey Stauffer, Sandra S Burkett, Betty K Martin, Eileen Southon, Scott C Sizemore,[...]. Hum Mol Genet 2012
41
50

Biallelic germline BRCA1 mutations in a patient with early onset breast cancer, mild Fanconi anemia-like phenotype, and no chromosome fragility.
Katharina Keupp, Stephanie Hampp, Annette Hübbel, Monika Maringa, Sarah Kostezka, Kerstin Rhiem, Anke Waha, Barbara Wappenschmidt, Roser Pujol, Jordi Surrallés,[...]. Mol Genet Genomic Med 2019
11
50

Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype.
Sarah L Sawyer, Lei Tian, Marketta Kähkönen, Jeremy Schwartzentruber, Martin Kircher, Jacek Majewski, David A Dyment, A Micheil Innes, Kym M Boycott, Lisa A Moreau,[...]. Cancer Discov 2015
197
50

VACTERL-H Association and Fanconi Anemia.
B P Alter, P S Rosenberg. Mol Syndromol 2013
43
50

Chromosome instability syndromes.
A Malcolm R Taylor, Cynthia Rothblum-Oviatt, Nathan A Ellis, Ian D Hickson, Stefan Meyer, Thomas O Crawford, Agata Smogorzewska, Barbara Pietrucha, Corry Weemaes, Grant S Stewart. Nat Rev Dis Primers 2019
42
50

Biallelic BRCA2 mutations in two black South African children with Fanconi anaemia.
Candice Feben, Careni Spencer, Anneline Lochan, Nakita Laing, Karen Fieggen, Engela Honey, Tasha Wainstein, Amanda Krause. Fam Cancer 2017
7
50

Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2.
Blanche P Alter, Philip S Rosenberg, Lawrence C Brody. J Med Genet 2007
159
50

Biallelic BRCA2 mutations are associated with multiple malignancies in childhood including familial Wilms tumour.
S Reid, A Renwick, S Seal, L Baskcomb, R Barfoot, H Jayatilake, K Pritchard-Jones, M R Stratton, A Ridolfi-Lüthy, N Rahman. J Med Genet 2005
70
50

Development of primary early-onset colorectal cancers due to biallelic mutations of the FANCD1/BRCA2 gene.
Emilie Degrolard-Courcet, Joanna Sokolowska, Marie-Martine Padeano, Séverine Guiu, Myriam Bronner, Carole Chery, Fanny Coron, Côme Lepage, Caroline Chapusot, Catherine Loustalot,[...]. Eur J Hum Genet 2014
13
50

Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer.
Sarah Reid, Detlev Schindler, Helmut Hanenberg, Karen Barker, Sandra Hanks, Reinhard Kalb, Kornelia Neveling, Patrick Kelly, Sheila Seal, Marcel Freund,[...]. Nat Genet 2007
431
50

Biallelic deleterious BRCA1 mutations in a woman with early-onset ovarian cancer.
Susan M Domchek, Jiangbo Tang, Jill Stopfer, Dana R Lilli, Nancy Hamel, Marc Tischkowitz, Alvaro N A Monteiro, Troy E Messick, Jacquelyn Powers, Alexandria Yonker,[...]. Cancer Discov 2013
92
50

Genotype-phenotype associations in Fanconi anemia: A literature review.
Moisés O Fiesco-Roa, Neelam Giri, Lisa J McReynolds, Ana F Best, Blanche P Alter. Blood Rev 2019
45
50

Fanconi anemia and solid malignancies in childhood: a national retrospective study.
Aurore Malric, Anne-Sophie Defachelles, Thierry Leblanc, Brigitte Lescoeur, Brigitte Lacour, Michel Peuchmaur, Claude-Alain Maurage, Gaëlle Pierron, Delphine Guillemot, Catherine Dubois d'Enghien,[...]. Pediatr Blood Cancer 2015
24
50

Mechanism for survival of homozygous nonsense mutations in the tumor suppressor gene BRCA1.
Aaron Seo, Orna Steinberg-Shemer, Sule Unal, Silvia Casadei, Tom Walsh, Fatma Gumruk, Stavit Shalev, Akiko Shimamura, Nurten Ayse Akarsu, Hannah Tamary,[...]. Proc Natl Acad Sci U S A 2018
16
50

Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia.
Kenneth Offit, Orna Levran, Brian Mullaney, Katherine Mah, Khedoudja Nafa, Sat Dev Batish, Raffaella Diotti, Hildegard Schneider, Amie Deffenbaugh, Thomas Scholl,[...]. J Natl Cancer Inst 2003
118
50

Fanconi anemia: correlating central nervous system malformations and genetic complementation groups.
Benjamin A Johnson-Tesch, Rakhee S Gawande, Lei Zhang, Margaret L MacMillan, David R Nascene. Pediatr Radiol 2017
8
50


Hepatoblastoma in a 4-year-old girl with Fanconi anaemia.
Sascha Kopic, Katharina Eirich, Beatrice Schuster, Helmut Hanenberg, Raymonda Varon-Mateeva, Olaf Rittinger, Günther Schimpl, Detlev Schindler, Neil Jones. Acta Paediatr 2011
16
50

Next-generation sequencing of BRCA1 and BRCA2 in breast cancer patients and control subjects.
Lubomir Balabanski, Georgi Antov, Ivanka Dimova, Samuil Ivanov, Maria Nacheva, Ivan Gavrilov, Desislava Nesheva, Blaga Rukova, Savina Hadjidekova, Maxim Malinov,[...]. Mol Clin Oncol 2014
8
25


Increased prevalence of the BRCA2 polymorphic stop codon K3326X among individuals with familial pancreatic cancer.
Sean T Martin, Hiroyuki Matsubayashi, Carmelle D Rogers, Juliet Philips, Fergus J Couch, Kieran Brune, Charles J Yeo, Scott E Kern, Ralph H Hruban, Michael Goggins. Oncogene 2005
59
25

Association of BRCA2 K3326* With Small Cell Lung Cancer and Squamous Cell Cancer of the Skin.
Thorunn Rafnar, Gudbjorg R Sigurjonsdottir, Simon N Stacey, Gisli Halldorsson, Patrick Sulem, Luba M Pardo, Hannes Helgason, Stefan T Sigurdsson, Thorkell Gudjonsson, Laufey Tryggvadottir,[...]. J Natl Cancer Inst 2018
14
25


RAD-ical New Insights into RAD51 Regulation.
Meghan R Sullivan, Kara A Bernstein. Genes (Basel) 2018
43
25

Reevaluation of the BRCA2 truncating allele c.9976A > T (p.Lys3326Ter) in a familial breast cancer context.
Ella R Thompson, Kylie L Gorringe, Simone M Rowley, Na Li, Simone McInerny, Michelle W Wong-Brown, Lisa Devereux, Jason Li, Alison H Trainer, Gillian Mitchell,[...]. Sci Rep 2015
17
25

Variants in the GH-IGF axis confer susceptibility to lung cancer.
Matthew F Rudd, Emily L Webb, Athena Matakidou, Gabrielle S Sellick, Richard D Williams, Helen Bridle, Tim Eisen, Richard S Houlston. Genome Res 2006
94
25

A protective role for BRCA2 at stalled replication forks.
Gurushankar Chandramouly, Nicholas A Willis, Ralph Scully. Breast Cancer Res 2011
4
25

ATM activation and its recruitment to damaged DNA require binding to the C terminus of Nbs1.
Zhongsheng You, Charly Chahwan, Julie Bailis, Tony Hunter, Paul Russell. Mol Cell Biol 2005
315
25

Genome-wide meta-analysis identifies eight new susceptibility loci for cutaneous squamous cell carcinoma.
Kavita Y Sarin, Yuan Lin, Roxana Daneshjou, Andrey Ziyatdinov, Gudmar Thorleifsson, Adam Rubin, Luba M Pardo, Wenting Wu, Paul A Khavari, Andre Uitterlinden,[...]. Nat Commun 2020
7
25

The checkpoint kinases Chk1 and Chk2 regulate the functional associations between hBRCA2 and Rad51 in response to DNA damage.
E M Bahassi, J L Ovesen, A L Riesenberg, W Z Bernstein, P E Hasty, P J Stambrook. Oncogene 2008
108
25

Mapping the physical and functional interactions between the tumor suppressors p53 and BRCA2.
Sridharan Rajagopalan, Antonina Andreeva, Trevor J Rutherford, Alan R Fersht. Proc Natl Acad Sci U S A 2010
33
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.